ARCHIMED
Gilles Guillemette is a seasoned leader in the animal health sector with extensive experience across various executive roles. Currently serving as Operating Partner for Animal Health at ARCHIMED since March 2023, Guillemette previously held the position of General Manager at Trupanion and Vice President of Healthcare Services at Chewy. Noteworthy roles include Vice President and Global Head of Animal Care Expansion at Elanco, and responsibilities for the OTC Business Unit at Eli Lilly within Elanco. Guillemette also served as Vice President & General Manager for Pharmaceutical and Nutritional Products at Henry Schein, and led business planning and strategy for North America's animal health operations at Bayer Health Care. Earlier in the career, Guillemette directed the US Animal Health division at Janssen, establishing the North American business unit, and held a Vice Presidential role at VetCentric that focused on online veterinary pharmacies. Guillemette earned a DVM from Ecole Nationale Veterinaire de Nantes and a degree in Food Processing Engineering from ENITIAA.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.